This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...

A recent study discovered that an inexpensive HIV drug could be effective for diabetic people by reversing a complication ...

Night blindness is caused by vitamin A deficiency, congenital mutations, and other eye diseases. Learn about symptoms, causes ...

New study shows cheap HIV drug lamivudine helps diabetic macular edema, improving vision. Oral option could replace eye ...

Our eyes are one of the most important organs of our body, and not only are they our tool to see the outside world, but they can also be a reflection of our health. Changes in our eyes are not always ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

From players to watch to pedigree and much more, we set out what to epect from Portugal at the European Championship ...

Researchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in ...

Two-year data from a phase 1/2 trial of eyeDNA Therapeutics' gene therapy for retinitis pigmentosa sets up pivotal trials, says the new biotech.

Los Angeles David Geffen School of Medicine and the Doheney Eye Institute, the VAC will be a strategic team informing Nanoscope’s scientific, clinical, and community-facing efforts. “As retina ...